K Number
K214086
Manufacturer
Date Cleared
2022-12-15

(353 days)

Product Code
Regulation Number
872.3660
Panel
Dental
Reference & Predicate Devices
Predicate For
N/A
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

Impression of inlay, onlay crown, and bridge preparation

  • Crown, bridge impression
  • Inlay and onlay impression
  • Functional impression
  • Denture impression
  • Study model impression
Device Description

Bright Impress impression material is a fast-set of addition-reaction silicone elastomer (Vinyl polysiloxane)-based material for dental professionals, consisting of five types (Light, Medium, Heavy, Bite and Putty) with superior hydrophilicity, dimensional accuracy, high tensile strength, and resistant to deformation. It is designed for versatile impression techniques of crowns, bridges, orthodontics and implants.

AI/ML Overview

The document is a 510(k) Summary for the dental impression material "Bright Impress" by Genoss Co., Ltd. It compares the characteristics of Bright Impress to a predicate device, HySil Impression Materials, and presents performance and biocompatibility data.

Here's an analysis of the provided information regarding acceptance criteria and the study that proves the device meets them:

1. A table of acceptance criteria and the reported device performance

The document provides extensive tables for both biocompatibility and performance for each variant of "Bright Impress" (Light, Medium, Heavy, Putty, Bite). I will consolidate and present a representative sample, focusing on the "Performance Data" which directly addresses how the device meets physical/mechanical acceptance criteria. The "Biocompatibility Data" also uses "Acceptance Criteria" and "P/F" (Pass/Fail) results.

Comprehensive Table of Acceptance Criteria and Reported Device Performance

CategoryItemAcceptance CriteriaReported Performance (Bright Impress - Light)Reported Performance (Bright Impress - Medium)Reported Performance (Bright Impress - Heavy)Reported Performance (Bright Impress - Putty)Reported Performance (Bright Impress - Bite)
Biocompatibility (All variants)
CytotoxicityNone cytotoxicityPassPassPassPassPassPass
SensitizationNone sensitizationPassPassPassPassPassPass
Irritation/ Intracutaneous ReactivityNone irritation/intracutaneous reactivityPassPassPassPassPassPass
Systemic Toxicity (acute)None systemic toxicityPassPassPassNot reported for HeavyPassPass
Oral Mucosa IrritationNone irritation (Heavy)PassNot reported for Light/Medium/Putty/BiteNot reported for Light/Medium/Putty/BitePassNot reported for Light/Medium/Putty/BiteNot reported for Light/Medium/Putty/Bite
Performance
VisualNo substance materialPassPassPassPassPassPass
Volume/CapacitySize error of Standard Size < ±5%PassPassPassPassPassPass
PackageNo damagePassPassPassPassPassPass
ColorContrasting color of base and catalystPassPassPassPassPassPass
Consistency≥ 36mm (Light)42.7mm31mm~41mm (Reported: 39.0mm)≤ 35mm (Reported: 27.0mm)≤ 35mm (Reported: 26.0mm)Not applicable for Bite
Working Time≥ 120 sec (Light)126sec≥ 90 sec (Reported: 117sec)≥ 60 sec (Reported: 112sec)≤ 30 sec (Reported: 30sec)≤ 30 sec (Reported: Pass)
Detail Reproduction20µm reproduction without interruption (Light/Medium) 50µm reproduction without interruption (Heavy) 75µm reproduction without interruption (Putty)Pass (20µm)Pass (20µm)Pass (50µm)Pass (75µm)Not reported for Bite
Compatibility with Gypsum50µm reproduction without interruption (Light/Medium/Heavy) 75µm reproduction without interruption (Putty)PassPassPassPassNot reported for Bite
Linear Dimensional Change≤ 1.5% (All except Bite for specific value)0.15%0.18%0.0%0.07%≤ 1.5% (Reported: Pass)
Elastic Recovery≥ 96.5% (Light/Medium/Heavy/Putty)98.48%99.18%99.00%97.98%Not reported for Bite
Strain in Compression2.020% (Light/Medium) 0.820% (Heavy/Putty)2.54%2.26%1.7%1.06%Not reported for Bite
Minimum Residence Time in Mouth≤ 90sec (Bite)Not applicable for Light/Medium/Heavy/PuttyNot applicable for Light/Medium/Heavy/PuttyNot applicable for Light/Medium/Heavy/PuttyNot applicable for Light/Medium/Heavy/Putty≤ 90sec (Reported: Pass)
Hardness≥ 20HD (Bite)Not applicable for Light/Medium/Heavy/PuttyNot applicable for Light/Medium/Heavy/PuttyNot applicable for Light/Medium/Heavy/PuttyNot applicable for Light/Medium/Heavy/Putty≥ 20HD (Reported: Pass)
Flexural Strength≥ 8.0N (Bite)Not applicable for Light/Medium/Heavy/PuttyNot applicable for Light/Medium/Heavy/PuttyNot applicable for Light/Medium/Heavy/PuttyNot applicable for Light/Medium/Heavy/PuttyPass
Recovery after Deformation< 0.1mm (Bite)Not applicable for Light/Medium/Heavy/PuttyNot applicable for Light/Medium/Heavy/PuttyNot applicable for Light/Medium/Heavy/PuttyNot applicable for Light/Medium/Heavy/Putty< 0.1mm (Reported: Pass)

Important Note: The document often states "Pass" for certain criteria in the performance tables where a specific numerical result might be expected (e.g., Working Time for Bright Impress - Bite, Flexural Strength for Bright Impress - Bite). This indicates that the device met the specified quantitative acceptance criteria, even if the exact number isn't explicitly shown in that particular table. The "Technological Characteristics" section comparing to the predicate does provide specific numbers for some of these.

2. Sample size used for the test set and the data provenance

  • Sample Size: The document does not explicitly state the sample sizes used for the performance and biocompatibility tests. It lists "Report No." for biocompatibility tests, suggesting external lab reports, but these reports are not provided. For performance, it lists Method (e.g., ISO 4823, DIN 13903) which implies standardized testing procedures that would define sample sizes, but the actual numbers of samples tested are not given.
  • Data Provenance: The manufacturer is Genoss Co., Ltd., located in Suwon-si, Gyeonggi-do, Korea, South. The document doesn't specify if the testing was done in Korea or elsewhere. The studies appear to be prospective bench tests and biocompatibility assessments conducted to demonstrate equivalency for regulatory clearance, rather than retrospective or prospective clinical studies on human subjects.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

This information is not applicable to the type of study described. The document outlines bench testing (physical and mechanical properties) and biocompatibility testing of a medical device material. The "ground truth" here is established by adherence to international standards (ISO, DIN) and objective measurements using laboratory equipment, not by human expert consensus on clinical data.

4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

This is not applicable. Adjudication methods like 2+1 or 3+1 are used in clinical studies, particularly for image interpretation or diagnosis where multiple readers provide opinions, and a consensus process is needed to establish ground truth. The studies described are bench tests and biocompatibility assessments, which rely on objective measurements and established protocols.

5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

This is not applicable. This document describes the clearance of a dental impression material, not an AI-powered diagnostic device. Therefore, no MRMC study or assessment of human reader improvement with AI assistance was performed or reported.

6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

This is not applicable. This device is a material, not software or an algorithm.

7. The type of ground truth used (expert concensus, pathology, outcomes data, etc)

The "ground truth" for the tests performed is based on:

  • International Standards: Adherence to established ISO (International Organization for Standardization) and DIN (Deutsches Institut für Normung) standards for dental materials, which define methods and acceptance criteria for properties like consistency, working time, dimensional change, elastic recovery, and detail reproduction.
  • Objective Laboratory Measurements: Data obtained from quantitative measurements in a laboratory setting (e.g., electronic scale for volume, specific instruments for consistency, hardness, flexural strength).
  • Biocompatibility Protocol Compliance: Results from standardized biological tests (e.g., Cytotoxicity, Sensitization, Irritation) following ISO 10993 guidelines, indicating the material's interaction with biological systems.

Essentially, the ground truth is objective scientific measurement and compliance with established performance and safety standards.

8. The sample size for the training set

This is not applicable. This is not an AI/machine learning device, so there is no concept of a "training set."

9. How the ground truth for the training set was established

This is not applicable as there is no training set for this type of device.

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.

December 15, 2022

Genoss Co., Ltd. Woojung Park Staff 1F, Gyeonggi R&DB Center, 105 Gwanggyo-ro, Yeongtong-gu Suwon-si, Gyeonggi-do 16229 Korea, South

Re: K214086

Trade/Device Name: Bright Impress-Light, Bright Impress-Medium, Bright Impress-Heavy, Bright Impress-Bite, Bright Impress-Putty Regulation Number: 21 CFR 872.3660 Regulation Name: Impression Material Regulatory Class: Class II Product Code: ELW Dated: November 16, 2022 Received: November 16, 2022

Dear Woojung Park:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's

{1}------------------------------------------------

requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see

https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely,

Bobak Shirmohammadi -S

For Michael E. Adjodha, M. ChE. Assistant Director DHT1B: Division of Dental and ENT Devices OHT1: Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Indications for Use

510(k) Number (if known) K214086

Device Name

Bright Impress - Light, Bright Impress - Medium, Bright Impress - Putty, Bright Impress - Bite

Indications for Use (Describe)

Impression of inlay, onlay crown, and bridge preparation

  • Crown, bridge impression
  • Inlay and onlay impression
  • Functional impression
  • Denture impression
  • Study model impression
Type of Use (Select one or both, as applicable)
---------------------------------------------------

|X Prescription Use (Part 21 CFR 801 Subpart D)

| Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

Image /page/3/Picture/0 description: The image shows the logo for GENOSS. The word "GENOSS" is written in a sans-serif font. The letters "GENO" are in a dark green color, while the letters "SS" are in a lighter green color. The logo is simple and modern.

510(k) Summary

K214086

1. Company

Submitter
NameGENOSS Co., Ltd.
Address1F, Gyeonggi R&DB Center / 226, 2F, GSBC, 105Gwanggyo-ro, Yeongtong-gu, Suwon-si, Gyeonggi-do, Korea
Phone/Fax+82-70-7098-8938/ +82-31-888-5105
Contact personWoojung Park / RAwjpark@genoss.com
Summary Date12/11/2021

2. Device Name

Proprietary name:Bright Impress – Light, Bright Impress – Medium,Bright Impress – Heavy, Bright Impress – Putty,Bright Impress – Bite
Regulation description:Impression Material
Classification name:Dental Impression Material
Common Name:Material, Impression

3. Predicate Device

K170736

Hysil Impression Materials

4. Description

Bright Impress impression material is a fast-set of addition-reaction silicone elastomer (Vinyl polysiloxane)-based material for dental professionals, consisting of five types (Light, Medium, Heavy, Bite and Putty) with superior hydrophilicity, dimensional accuracy, high tensile strength, and resistant to deformation. It is designed for versatile impression techniques of crowns, bridges, orthodontics and implants.

{4}------------------------------------------------

Image /page/4/Picture/0 description: The image shows the word "GENOSS" in a stylized font. The first three letters, "GEN", are in a dark green color. The last three letters, "OSS", are in a lighter green color. The letters are connected to each other.

5. Technological Characteristics

Bright Impress was compared with the predicate device 'HySil Impression Material' in clinical, technical, biological view. The characteristics that differed from the predicate device were performed by gap analysis, which confirmed equivalence with the predicate device. Technological characteristics of Bright Impress and HySil Impression Material are as following;

5.1 Bright Impress – Heavy, Bright Impress – Medium, Bright Impress – Light, Bright Impress – Putty

Device nameBright Impress-Heavy,Bright Impress-Medium,Bright Impress-Light,Bright Impress-PuttyHySil-Heavy, Mono, Light, Putty
ManufactureGenoss Co.,Ltd.Osstem Implant Co., Ltd.
510(K) NumberNew deviceK170736
Target populationHuman toothHuman tooth
ClinicalIndication for useImpression of inlay, onlay crown, andbridge preparation- Crown, bridge impression- Inlay and onlay impression- Functional impression- Denture impression- Study model impressionHySil Putty is to be used aspreliminary materials for:- Two-step Putty-washimpression technique- One-step Putty-washimpression techniqueHySil Heavy is to be used asheavy-bodies materials for:- One-step impression technique(simultaneous technique) usingsingle or dual viscosities- Two-step impression techniqueusing dual viscosities- Functional impressionHySil Mono is to be used as amedium-bodies tray or syringeableimpression material for:- Taking impressions over fixed /removable restorations and implants(i.e., transferring impression postsand bridge components)- Functional impression

{5}------------------------------------------------

Image /page/5/Picture/0 description: The image shows the word "GENOSS" in green font. The first three letters, "GEN", are in a darker shade of green, while the last three letters, "OSS", are in a lighter shade of green. The font is sans-serif and appears to be bold.

- Fabricating full or partialdentures - Reline impressions - Use in the simultaneous mixingtechnique as well as the putty-washand triple tray techniques - Transferring root posts when fabricating posts and cores indirectlyHySil Light is to be used assyringeable impression materials for: - Two-step putty-washimpression technique - One-step putty-washimpression technique - Two-step impression technique using dual viscosities - Reline impression - Fabricating full or partialdentures
Site of applicationHuman teethHuman teeth
TypeLightMediumHeavyPuttyLightMonoHeavyPutty
Type of ISO483232103210
Working Time126sec117sec112sec-2.850min2.612min2.022min-
Mixing Time---30sec---38sec
TechnicalConsistency42.7mm39.0mm27.0mm26.0mm45.60mm35.65mm28.47mm31.27mm
Compatibility withGypsumPassPassPassPassPassPassPassPass
Linear Dimensionalchange0.15%0.18%0.0%0.07%0.03%0.02%0.02%0.031%
Elastic recovery98.48%99.18%99.00%97.9898.7%98.6%98.8%99.8%
Strain-incompression2.54%2.26%1.7%1.06%2.30%3.00%2.30%1.6%
MaterialPolyvinyl SiloxanePolyvinyl Siloxane
BiologicalChemical SafetyBiocompatibleBiocompatible
SterilizationNon sterileNon sterile

{6}------------------------------------------------

Image /page/6/Picture/0 description: The image contains the word "GENOSS" in a stylized font. The first four letters, "GENO", are in a dark green color, while the last three letters, "OSS", are in a lighter green color. The letters are connected and have a rounded appearance.

5.2 Bright Impress – Bite

Device nameBright Impress-BiteHySil-Bite
ManufactureGenoss Co.,Ltd.Osstem Implant Co., Ltd.
510(K) NumberNew deviceK170736
Target populationHuman toothHuman tooth
ClinicalIndication for useImpression of inlay, onlay crown, andbridge preparation- Crown, bridge impression- Inlay and onlay impression- Functional impression- Denture impression- Study model impressionHySil Bite is used for impressionas below:- Taking occlusal surfaces- confirming occlusal surfaces- Recording after putting thearticulator
Site of applicationHuman teethHuman teeth
Working TimePassPass
Minimum residencetime in the mouth≤ 90sec≤ 90sec
Hardness≥ 20HD50 HD
Flexural StrengthPassPass
TechnicalRecovery afterdeformation< 0.1mm< 0.1mm
Linear Dimensionalchange≤ 1.5%-0.16 %
MaterialPolyvinyl SiloxanePolyvinyl Siloxane
BiologicalChemical SafetyBiocompatibleBiocompatible
SterilizationNon sterileNon sterile

6. Indication for use

Impression of inlay, onlay crown, and bridge preparation

  • Crown, bridge impression
  • Inlay and onlay impression
  • Functional impression
  • Denture impression
  • Study model impression

510(k) Summary

{7}------------------------------------------------

Image /page/7/Picture/0 description: The image shows the word "GENOSS" in green font. The first four letters, "GENO", are in a darker green, while the last two letters, "SS", are in a lighter green. The font is bold and sans-serif. The letters are all capitalized.

7. Biocompatibility Data

Biocompatibility testing on the proposed Bright Impress has been completed. Requirements for biological evaluation of the proposed device were based on FDA recognized concensus standard of ISO10993, "Biological Evaluation of Medical Devices, Part 1: Evaluation and Testing." The biocompatibility test results show that the materials used in the design and manufacture of the components of the proposed device are non-toxic and non-sensitizing to biological bone and tissues with its intended use. The following biocompatibility tests were completed:

7.1 Bright Impress - Light

(P: Pass, F: Fail)

No.TestMethodAcceptance criteriaP/FReport No.
1Cytotoxicity (MEM Test)ISO 10993-05None cytotoxicityPMGK-2022-001757
2SensitizationISO 10993-10None sensitizationPMTK-2019-000355
3Irritation or intracutaneousreactivityISO 10993-10None irritationPMTK-2019-000355
4Systemic toxicity(acute)ISO 10993-11None systemictoxicityPMTK-2019-000355

7.2 Bright Impress - Medium

(P: Pass, F: Fail)

No.TestMethodAcceptance criteriaP/FReport No.
1Cytotoxicity (MEM Test)ISO 10993-05None cytotoxicityPMGK-2022-001756
2SensitizationISO 10993-10None sensitizationPMTK-2019-000357
3Irritation or intracutaneousreactivityISO 10993-10None irritationPMTK-2019-000357
4Systemic toxicity(acute)ISO 10993-11None systemic toxicityPMTK-2019-000357

{8}------------------------------------------------

Image /page/8/Picture/0 description: The image shows the logo for GENOSS. The word "GEN" is in dark green, while "OSS" is in a lighter green. The font is sans-serif and bold.

7.3 Bright Impress - Heavy

(P: Pass, F: Fail)

No.TestMethodAcceptance criteriaP/FReport No.
1Cytotoxicity (MEM Test)ISO 10993-05None cytotoxicityPMGK-2022-001758
2SensitizationISO 10993-10None sensitizationPMTK-2018-000723
3Oral Mucosa IrritationISO 10993-10None irritationPMTK-2018-000724

7.4 Bright Impress - Putty

(P: Pass, F: Fail)

No.TestMethodAcceptance criteriaP/FReport No.
1Cytotoxicity (MEM Test)ISO 10993-05None cytotoxicityPMGK-2022-001755
2SensitizationISO 10993-10None sensitizationPMTK-2019-000359
3Irritation or intracutaneousreactivityISO 10993-10None irritationPMTK-2019-000359
4Systemic toxicity(acute)ISO 10993-11None systemic toxicityPMTK-2019-000359

7.5 Bright Impress - Bite

(P: Pass, F: Fail)

No.TestMethodAcceptance criteriaP/FReport No.
1Cytotoxicity (MEM Test)ISO 10993-05None cytotoxicityPMGK-2022-001759
2SensitizationISO 10993-10None sensitizationPMTK-2019-000327
3Irritation or intracutaneousreactivityISO 10993-10None irritationPMTK-2019-000326
4Systemic toxicity(acute)ISO 10993-11None systemic toxicityPMTK-2019-000328

{9}------------------------------------------------

Image /page/9/Picture/0 description: The image shows the word "GENOSS" in a stylized font. The first three letters, "GEN", are in a dark green color. The last three letters, "OSS", are in a lighter green color. The font is sans-serif and has a modern look.

8. Performance Data

The proposed Bright Impress was evaluated using the following performance bench testing to confirm the performance characteristics:

8.1 Bright Impress - Light

No.ItemsPropertiesMethodDoc No.
1VisualNo substance materialVisual inspection
2VolumeSize error of Standard Size < ±5%Electronic Scale
3PackageNo damageVisual Inspection
4ColorContrasting color of base and catalystVisual Inspection
5Consistency$ \geq 36mm $ISO 4823
6Working Time$ \geq 120 sec $ISO 4823
7Detail reproduction20μm reproduction without interruptionISO 4823제19-02-019호
8compatibility withgypsum50μm reproduction without interruptionISO 4823
9Linear Dimensionalchange$ \leq 1.5% $ISO 4823
10Elastic recovery$ \geq 96.5% $ISO 4823
11Strain in compression2.0~20%ISO 4823

8.2 Bright Impress – Medium

No.ItemsPropertiesMethodDoc No.
1VisualNo substance materialVisual inspection
2VolumeSize error of Standard Size < ±5%Electronic Scale
3PackageNo damageVisual Inspection
4ColorContrasting color of base and catalystVisual Inspection
5Consistency31mm~41mmISO 4823
6Working Time≥ 90 secISO 4823
7Detail reproduction20µm reproduction without interruptionISO 4823제19-02-022호
8compatibility withgypsum50µm reproduction without interruptionISO 4823
9Linear Dimensionalchange≤ 1.5%ISO 4823
10Elastic recovery≥ 96.5%ISO 4823
11Strain in compression2.0~20%ISO 4823

{10}------------------------------------------------

Image /page/10/Picture/0 description: The image shows the word "GENOSS" in a stylized font. The letters "GENO" are in a dark green color, while the letters "SS" are in a lighter green color. The font is sans-serif and has a modern look.

8.3 Bright Impress – Heavy

No.ItemsPropertiesMethodDoc No.
1VisualNo substance materialVisual inspection
2CapacitySize error of Standard Size < ±5%Electronic Scale
3PackageNo damageVisual Inspection
4Component ColourContrasting color of base and catalystVisual Inspection
5Consistency≤ 35mmISO 4823
6Working Time≥ 60 secISO 4823
7Detail Reproduction50µm reproduction without interruptionISO 4823CDM-18-0065
8Compatibility withCypsum50µm reproduction without interruptionISO 4823
9Linear DimensionalChange≤ 1.5%ISO 4823
10Elastic Recovery≥ 96.5%ISO 4823
11Strain-in-compression0.8~20%ISO 4823

8.4 Bright Impress – Putty

No.ItemsPropertiesMethodDoc No.
1VisualNo substance materialVisual inspection
2VolumeSize error of Standard Size $\lt \pm$ 5%Electronic Scale
3PackageNo damageVisual Inspection
4ColorContrasting color of base andcatalystVisual Inspection
5Consistency$\leq$ 35mmISO 4823제19-02-016호
6Working Time$\leq$ 30 secISO 4823
7Detail reproduction75 $\mu$ m reproduction without interruptionISO 4823
8compatibility withgypsum75 $\mu$ m reproduction without interruptionISO 4823
9Linear Dimensionalchange$\leq$ 1.5%ISO 4823
10Elastic recovery$\geq$ 96.5%ISO 4823
11Strain in compression0.8~20%ISO 4823

{11}------------------------------------------------

Image /page/11/Picture/0 description: The image shows the word "GENOSS" in a stylized font. The first four letters, "GENO," are in a dark green color, while the last three letters, "OSS," are in a lighter green shade. The letters are connected, giving the word a continuous, flowing appearance.

8.5 Bright Impress – Bite

No.ItemsPropertiesMethodDoc No.
1VisualNo substance materialVisual inspection
2VolumeSize error of Standard Size < ±5%Electronic Scale
3PackageNo damageVisual Inspection
4ColorContrasting color of base and catalystVisual Inspection
5Working Time≤ 30 secDIN 13903
6Minimum residencetime in the mouth≤ 90secDIN 13903제19-02-045호
7Hardness≥ 20HDDIN 13903
8Flexural Strength≥ 8.0NDIN 13903
9Recovery afterdeformation< 0.1mmDIN 13903
10Linear Dimensionalchange≤ 1.5%DIN 13903

All test results demonstrate that the materials chosen, the manufacturing process, and the design utilized for the Bright Impress met the established specifications necessary for consistent performance according to its intended use.

9. Conclusion

Based on the information provided in this premarket notification of GENOSS Co., Ltd. concluded that Bright Impress is acceptable and safe, substantially equivalent to predicate device.

§ 872.3660 Impression material.

(a)
Identification. Impression material is a device composed of materials such as alginate or polysulfide intended to be placed on a preformed impression tray and used to reproduce the structure of a patient's teeth and gums. The device is intended to provide models for study and for production of restorative prosthetic devices, such as gold inlays and dentures.(b)
Classification. Class II (Special Controls).